How to buy Pfizer (PFE) stock

Pfizer (NYSE: PFE) is a multinational pharmaceutical company based in the United States. It is one of the world’s biggest pharmaceutical corporations and ranked 77th on the Fortune 500 in 2021. Since Pfizer is considered a large-cap value company, suggesting it may not see the rapid growth of, say, a relatively new tech company. However, Pfizer offers a strong dividend that has increased since mid-2009, and in 2022, its stock price was less volatile than most of its competitors.

Throughout the globe, Pfizer Inc. is listed on four stock exchanges, including the New York Stock Exchange (NYSE), Paris Euronext, the London Stock Exchange (LSE), and the SIX Swiss Exchange. Investors who want to buy Pfizer stocks online must need an online trading platform to access the New York Stock Exchange (NYSE), the world’s largest stock exchange.

How to buy Pfizer stock with a Brokerage Account

If you are interested in investing in Pfizer, you’ll need to get set up with a broker to buy stock. A broker, allows you to execute trades either by actually owning a financial product such as Pfizer shares or by trading on Contract of Differences (CFDs). Both ways of investment are good and each comes with its benefits. You’ll need to carefully select which firm fits best with your financial goals and needs.

You can open an account with an online brokerage or a full-service brokerage (a more expensive choice). If you want to buy Pfizer stock, but would like more support and advice along the way, you could opt to use a full-service broker. This kind of broker may offer advice on which companies to invest in and how to build a portfolio of shares and other assets. They may also be able to offer advice on related areas such as retirement planning and tax. Often called discount brokers, online brokers are typically less expensive and allow you to buy or sell Pfizer stock and other investments directly through their websites or trading platforms with no commission charge. Some of most trust brokerages are Robinhood, Webull, Interactive Brokers, Charles Schwab, and more.

How to buy Pfizer stock through Direct Investment

If you’d prefer to invest just a few stocks, many blue-chip companies offer plans that make it possible to purchase their stock directly. As a big pharma company, you can also buy Pfizer shares directly from the company. To do this, you’ll need to contact the company’s transfer agent, Computershare Trust Company. The Computershare CIP ("CIP") allows investors of Pfizer Inc. to directly purchase and sell shares of company common stock and reinvest dividends. The CIP is a direct stock purchase and dividend reinvestment plan administered by Computershare Trust Company, N.A., not by Pfizer. Please contact Computershare for further information.

How to Invest in Pfizer with an ETF or an Index Fund

Putting too much of your portfolio in a single company can be risky. To reduce your level of risk, it’s a good idea to invest in many companies rather than just one. Consider investing in index funds or exchange-traded funds (ETFs) instead of buying individual shares of many different companies on your own. As a large company, the company’s stock is included in dozens of health care, pharmaceutical, and dividend index funds and ETFs. Most of them you can choose to invest in are iShares U.S. Pharmaceuticals ETF (IHE), Health Care Select Sector SPDR Fund (XLV), and Invesco Dynamic Pharmaceuticals ETF (PJP).

If you’re not sure which investment type is best for you, consult with an investment advisor to review your options.

How to buy Pfizer stock with an advisor

Remember that past performance isn’t a guide to the future. The value of your investment in Pfizer or any other stock can fall as well as rise and you may get back less than you invested. So, it’s crucial that you understand the company before you invest your hard-earned money.

Buying Pfizer shares on your own is not your only option. If you’re in any doubt about where you want to invest, you may want to seek financial advice to help you choose. Your financial advisor can help you aware of any risks and possible long-term implications of adapting your strategy. They’ll help figure out when it’s time to sell your shares, which can be a tricky decision. Simply tell your advisor that you want to invest in Pfizer, and he or she can help you do it.

Should you invest in Pfizer?

Pharmaceutical giant Pfizer has been at the front of the industry, developing treatments for COVID since the pandemic started. The COVID pandemic continues, and vaccination demand remains strong. The vast majority of doses administered in the U.S. have come from Pfizer and Moderna, two companies that developed the vaccines using mRNA technology. Pfizer's business has brought in billions in new revenue from its vaccine. The original forecast for 2021 called for 1.3 billion doses, however, it ended up making around 3 billion doses in 2021. Management is now forecasting that Pfizer will produce roughly 4 billion doses in 2022.

Pfizer's shares have soared this year due to its dominance in the COVID-19 vaccine market, as well as its late-stage trial success with the oral antiviral pill Paxlovid. As of the close of November, the shares were up by an astonishing 45.8% year to date, which is only slightly lower than Eli Lilly's industry-leading 47% gain in 2021. Despite this sizable jump in 2021, Pfizer seems primed to crush the broader market yet again in 2022.

Is Pfizer stock a buy now?

We now estimate Pfizer’s Valuation to be $58 per share, which is 9.25% above the current market price of $54.19. Right now, it trades at only about 13.8 times forward earnings estimates. And Pfizer also pays a solid dividend — with a yield of more than 2.9%. Well, right now looks like a great time to invest in Pfizer. As COVID remains firmly entrenched in our world, Pfizer remains poised for success in 2022.

The median 12-month Pfizer (PFE) stock price forecast from 15 analysts that have issued a rating was $60.87, as of March 22, ranging from $50 a share at the low end to a high of $76, according to MarketBeat. There were six ‘buy’ ratings and nine ‘hold’ recommendations, with no ‘sell’ ratings.

Whether PFE stock is a suitable investment for your portfolio depends on your personal circumstances and risk tolerance. You should evaluate the level of risk you are prepared to accept before investing. And never invest money that you cannot afford to lose.